Texas HB3828 prohibits the use of funds from the Cancer Prevention and Research Institute of Texas for embryonic or fetal stem cell research.

Texas HB3828 amends the Health and Safety Code to restrict the use of funds awarded by the Cancer Prevention and Research Institute of Texas. Specifically, it prohibits these funds from being used for embryonic or fetal stem cell research. However, it allows the use of such funds for research involving adult stem cells or stem cells obtained from an umbilical cord. The act's effective date depends on legislative approval, either taking immediate effect with a two-thirds majority vote or on September 1, 2025, if not approved.

Texas HB3828 prohibits the use of funds from the Cancer Prevention and Research Institute of Texas for embryonic or fetal stem cell research.

Texas HB3828 amends the Health and Safety Code to restrict the use of funds awarded by the Cancer Prevention and Research Institute of Texas. Specifically, it prohibits these funds from being used for embryonic or fetal stem cell research. However, it allows the use of such funds for research involving adult stem cells or stem cells obtained from an umbilical cord. The act's effective date depends on legislative approval, either taking immediate effect with a two-thirds majority vote or on September 1, 2025, if not approved.